rs376868997
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_000391.4(TPP1):c.688-18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00055 in 1,613,938 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000391.4 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152180Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000362 AC: 91AN: 251344Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135846
GnomAD4 exome AF: 0.000573 AC: 838AN: 1461758Hom.: 1 Cov.: 41 AF XY: 0.000517 AC XY: 376AN XY: 727192
GnomAD4 genome AF: 0.000322 AC: 49AN: 152180Hom.: 0 Cov.: 31 AF XY: 0.000336 AC XY: 25AN XY: 74340
ClinVar
Submissions by phenotype
not specified Benign:3
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Variant summary: TPP1 c.688-18C>T alters a nucleotide located at a position not widely known to affect splicing. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00036 in 251344 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in TPP1 causing Neuronal Ceroid-Lipofuscinosis (Batten Disease) (0.00036 vs 0.002), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.688-18C>T in individuals affected with Neuronal Ceroid-Lipofuscinosis (Batten Disease) and no experimental evidence demonstrating its impact on protein function have been reported. One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at